Akèy › Obèsite › Texas › Houston
Etid klinik pou Obèsite nan Houston, TX
43 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Juno Research /ID# 282413, Houston
- PlanIt Research /ID# 282204, Houston
- JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi lwen
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
- Cardiovascular Specialists of Willowbrook, Houston
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Ap rekriteFaz 3
- PlanIt Research, PLLC, Houston
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- DM Clinical, Houston
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Houston Research Institute, Houston
- The Endocrine Center, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Houston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Ap rekriteFaz 3
- McGovern Medical School, Houston
- Texas Childrens Hospital, Houston
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
- ak 1 plis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Juno Research, Houston
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
- Research Site, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- ak 2 plis
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- The University of Texas Health Science Center at Houston, Bellaire · 7 mi lwen
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Ap rekriteFaz 3
- Care Access - Houston, Houston
- JCCT - Juno Bellaire Site, Bellaire · 7 mi lwen
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- PlanIt Research, PLLC, Houston
Semaglutide for Post-Smoking Cessation Weight Management
Ap rekriteFaz 2Volontè an sante akeyi
- The University of Texas Health Science Center at Houston, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- ak 3 plis
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Ap rekriteFaz 2
- Juno Research, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Elevate Clinical, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, LLC, Bellaire · 7 mi lwen
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Houston Pulm Med Res Network, Houston
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Houston
- ACCOMPLISH-2 Research Site, Houston
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Houston Pulm Med Res Network, Houston
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- PlanIt Research, PLLC, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Ap rekriteFaz 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · 7 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- JCCT- Juno Northwest Houston, Houston
- Biopharma Informatic, LLC, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi lwen
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Bellaire · 7 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi lwen
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Biopharma Informatic, LLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Ap rekriteFaz 2
- Baylor Texas Children's Hospital, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- ak 1 plis
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Houston
- ACCOMPLISH-1 Research Site, Houston
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
Ap rekriteVolontè an sante akeyi
- Children's Nutrition Research Center, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
Ap rekriteVolontè an sante akeyiMande peman pou patisipan yo
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Lilli Health, Houston
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Ap rekrite
- M D Anderson Cancer Center, Houston
Incretin Microdosing for Cardiometabolic Health in People With HIV
Ap rekriteFaz 2
- The University of Texas Health Science Center at Houston, Houston
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Ap rekriteFaz 2
- Baylor College of Medicine, Houston
RESET System Pivotal Trial (Rev F)
Ap rekrite
- Baylor College of Medicine, Houston
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
Ap rekrite
- Houston Methodist Hospital, Houston
Etid Obèsite nan lòt vil
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL31 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD25 etid
- Jacksonville, FL25 etid
- St. Louis, MO25 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.